Etti Katz-Kadosh

Title: Etti Katz-Kadosh: Innovator in RNA Silencing Technologies

Introduction

Etti Katz-Kadosh is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of RNA silencing technologies, focusing on innovative methods for targeting p21 mRNA. With a total of 2 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Katz-Kadosh's latest patents include groundbreaking compositions of matter that comprise RNA silencing molecules capable of mediating cleavage of p21 mRNA. These inventions disclose methods for eradicating senescent cells or cancer cells, as well as approaches for treating senescence-associated diseases, cancer, and fibrotic diseases. Another notable patent involves a composition of matter that includes a DNAzyme molecule capable of mediating cleavage of p21 mRNA, with specific nucleic acid sequences that are at least 80% identical to designated sequences. This patent also outlines methods for addressing senescent cells and cancer.

Career Highlights

Etti Katz-Kadosh is currently associated with 1E Therapeutics Ltd., where she continues to advance her research and innovations. Her work is characterized by a commitment to developing effective treatments for serious health conditions.

Collaborations

Katz-Kadosh collaborates with notable colleagues, including Noam Pilpel and Yossi Ovadya, contributing to a dynamic research environment that fosters innovation.

Conclusion

Etti Katz-Kadosh stands out as a leading inventor in the field of RNA silencing technologies, with her patents paving the way for new therapeutic approaches. Her contributions are vital in the ongoing fight against diseases associated with senescence and cancer.